Transverse Medical, Inc.
PrivateLast Round
Series B
Extension
Apr 28, 2025
Total Funding Raised
$13.25M
Company Overview
Transverse Medical, Inc. operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Series B Extension round in April 2025.
Transverse Medical, Inc. is a biotechnology company that develops the POINT-GUARD™ Cerebral Embolic Protection device to reduce the risk of stroke during cardiovascular and structural heart procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transverse Medical, Inc. Comparables
Compare Transverse Medical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protembis GmbH | 91% | |
| Emboline | 90% | |
| Emblok | 88% |
For institutional investors. Book with your work email.
Transverse Medical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 28, 2025 | ||||
| Series B Extension | Aug 1, 2023 | ||||
| Grant | Nov 21, 2019 | ||||
| VC Round | May 24, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
Grew 50% QoQ, from 12 to 18 employees.
- Jun 4, 2025
Grew 45% QoQ from 11 to 16 employees.
For institutional investors. Book with your work email.
Transverse Medical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Transverse Medical, Inc.'s valuation, stock price, and market status.
Is Transverse Medical, Inc. a public or private company?
Transverse Medical, Inc. is a private company.
What is the current stock price of Transverse Medical, Inc.?
Transverse Medical, Inc. is a private company, so its shares have no public market price. Caplight tracks Transverse Medical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Transverse Medical, Inc. worth (valuation)?
Valuation information for Transverse Medical, Inc. is not publicly available.
Can I buy Transverse Medical, Inc. stock?
Transverse Medical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Transverse Medical, Inc.'s last funding round?
Transverse Medical, Inc.'s most recent funding round was Series B Extension on April 28, 2025.
Who are the main investors in Transverse Medical, Inc.?
Investor information for Transverse Medical, Inc. is not publicly disclosed.
Will Transverse Medical, Inc. IPO soon?
No public IPO plans have been announced for Transverse Medical, Inc..
How can I track Transverse Medical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Transverse Medical, Inc.'s shares on secondary markets.